NEUROCRINE BIOSCIENCES INC (NBIX)
US64125C1099 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 155. This target is 11.53% above the current price.
NBIX was analyzed by 35 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-24 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-04-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | Needham | Reiterate | Hold |
| 2024-04-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-08 | Mizuho | Maintains | Neutral -> Neutral |
| 2024-02-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-01-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-23 | Barclays | Maintains | Overweight -> Overweight |
| 2023-12-18 | Stifel | Maintains | Buy -> Buy |
| 2023-12-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-13 | Citigroup | Initiate | Neutral |
| 2023-12-12 | Deutsche Bank | Initiate | Buy |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-11-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-11-10 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023-11-10 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-11-03 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-11-01 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-11-01 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-11-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-10-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-13 | Mizuho | Reiterate | Neutral -> Neutral |